1 of 1
Story summary
- Dr. Tracy Beth Høeg was named acting director of FDA's Center for Drug Evaluation and Research.
- Senior FDA officials fear her lack of experience in drug reviews and trials could damage credibility.
- Høeg has advocated for stricter COVID vaccine guidelines and questioned the U.S. vaccination schedule.
- Critics, including former FDA leaders, say her proposed changes undermine vaccine safety.
- Her leadership follows abrupt resignations at the FDA, signaling management instability.
